Vanguard Group »

Immunic shares owned by Vanguard Group

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.5M 3.4M 1.32
2023-12-31 $2.5M 1.7M 1.50
2023-09-30 $2.4M 1.7M 1.47
2023-06-30 $4.2M 1.7M 2.51
2023-03-31 $2.2M 1.5M 1.49
2022-12-31 $1.5M 1.1M 1.40
2022-06-30 $3.1M 879k 3.47
2022-03-31 $11M 957k 11.30
2021-09-30 $7.8M 881k 8.85
2021-06-30 $8.7M 712k 12.22
2021-03-31 $12M 732k 15.97
2020-12-31 $10M 683k 15.25
2020-09-30 $12M 650k 18.57
2020-06-30 $3.0M 248k 12.17
2020-03-31 $70k 12k 6.09
2019-12-31 $112k 12k 9.71
2019-09-30 $121k 12k 10.53